Osteoarthritis, or rheumatism, is a joint disease that is mainly characterized by deteriorated cartilage in the joint, which is accompanied by mild inflammation and pain. Osteoarthritis is also commonly referred to as joint wear. Most people think that osteoarthritis is something simple, but osteoarthritis is a degenerative condition. Are you curious who all have osteoarthritis and what the latest news is? Please keep reading.
According to the latest figures, osteoarthritis mainly occurs from the age of 45. About 4.0% of all Dutch people suffered from osteoarthritis in 2007, which was 13 years ago. People older than 45 years had 12.4% of osteoarthritis. This percentage was considerably higher among the over-65s, namely 17.2%. The researchers now estimate this percentage to be considerably on the higher side. We don't know for sure how much it is yet.
The known figures are from a while ago. The Netherlands is aging and this means that the population is getting older. This has to do with the baby boomers. These baby boomers were all born after World War II and are now all over 65 years old. This means that today's figures may differ considerably. In addition, people suffer from different types of osteoarthritis:osteoarthritis in the foot, osteoarthritis in the knee, osteoarthritis in the hip, osteoarthritis in the shoulder, etc.
Reading tip:CBD oil helps to relieve pain in osteoarthritis
In the previous heading we mainly talked about the fact that osteoarthritis will increase and that the last figures have lost their reliability. However, we also have good news for you.
Japan develops groundbreaking treatment for osteoarthritis. As an experiment, a Japanese doctor decided to take a damaged cartilage with him after an operation. There, the doctor conducted experiments that will bring major changes to the treatment of osteoarthritis.
Unfortunately, it is not too early to celebrate… but Japan reports a major breakthrough in the treatment of this degenerative process. The Japanese have succeeded in making pluripotent stem cells from arthrosis-affected cartilage tissue.
What this will look like in practice and in the Netherlands is still unknown, but we do know that today's technology and knowledge will provide more insight into the treatment of osteoarthritis!
